Porth's Essentials of Pathophysiology, 4e

1139

Disorders of the Skeletal System: Metabolic and Rheumatic Disorders

C h a p t e r 4 4

57. Gladman DD. Psoriatic arthritis. In: Klippel JR, Stone JH, Crofford LJ, et al., eds. Primer on the Rheumatic Diseases . 13th ed. New York, NY: Springer; 2008:170–177. 58. Mease PJ. Current treatment of psoriatic arthritis. Rheum Dis Clin North Am. 2003;29:495–511. 59. Loeser RF, Goldring SR, Scanzello CR, et al. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;42(6):1697–1707. 60. Sinusas K. Osteoarthritis: diagnosis and treatment. Am Fam Physician. 2012;85(1):49–56. 61. Bijlsma JWJ, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377:2115–2126. 62. Hunter DJ, Lo GH. The management of osteoarthritis: an overview and call to appropriate conservative treatment. Rheum Dis Clin North Am. 2008;33:689–712. 63. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin 64. Lo GH, LaValley M, McAllindon T, et al. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta- analysis. JAMA. 2003;290:3115–3121. 65. Burns CM, Wortman RL. Clinical features and treatment of gout. In: Firestein GS, Budd RC, Gabriel SE, et al., eds. Kelley’s Textbook of Rheumatology . 9th ed. Philadelphia, PA: Elsevier Saunders; 2012:1554–1574. 66. Eggebeen AT. Gout: an update. Am Fam Physician. 2007;76:801–812. 67. Neogi T. Gout. N Engl J Med. 2011;364(5):443–452. 68. Khanna D, Fitzgerald JD, Khanna PP, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken). 2012;64(10):1431–1446. 69. Abramson L. Arthritis in children. American College of Rheumatology website. May 2013. Available at: http://www. rheumatology.org/Practice/Clinical/Patients/Diseases_And_ Conditions/Arthritis_in_Children/. Accessed September 29, 2013. 70. Wu EY, Van Mater HA, Rabinovich CE. Juvenile idiopathic arthritis. In: Kliegman RM, Stanton BF, Schor NF, et al., eds. Nelson Textbook of Pediatrics . 19th ed. Philadelphia, PA: Elsevier Saunders; 2011:829.e1–839.e1. 71. Marzan KAB, Shaham B. Early juvenile idiopathic arthritis. Rheum Dis Clin North Am. 2012;38:355–373. 72. Growdie PJ, Tse SML. Juvenile idiopathic arthritis. Pediatr Clin North Am. 2012;59:301–327. 73. Kahn P. Juvenile idiopathic arthritis: an update for the clinician. Bull NYU Hosp Jt Dis. 2012;70(3):152–166. 74. Harris JG, Kessler EA, Verbsky JW. Update on the treatment of juvenile idiopathic arthritis. Curr Allergy Asthma Rep. 2013;13:337–346. sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795–808.

75. Birmingham J, Colbert RA. Ankylosing spondylitis and other spondyloarthritides. In: Kliegman RM, Stanton BF, Schor NF, et al., eds. Nelson Textbook of Pediatrics , 19th ed. Philadelphia, PA: Elsevier Saunders; 2011:837.e3–839.e3. 76. Colbert RA. Classification of juvenile spondyloarthritis: enthesitis-related arthritis. Nat Rev Rheumatol. 2010;6(8):477–485. 77. Tee SM, Laxer RM. New advances in juvenile spondyloarthritis. Nat Rev Rheumatol. 2012;8(5):269–279. 78. Gensler L, Davis JC Jr. Recognition and treatment of juvenile-set spondyloarthritis. Curr Opin Rheumatol. 2006;18(5):507–511. 79. Stoll ML, Punaro M. Psoriatic juvenile idiopathic arthritis: a tale of two subgroups. Curr Opin Rheumatol. 2011;23(5):437–443. 80. Huber AM. Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment. Paediatr Drugs. 2009;11(6):361–374. 81. Batthish M, Feldman BM. Juvenile dermatomyositis. Curr Rheumatol Rep. 2011;13(3):216–224. 82. Cornell CN, Sculco TP. Orthopedic disorders. In: Duthie DH, Katz PR, Malone MI. Duthie: Practice of Geriatrics . 4th ed. Philadelphia, PA: Saunders Elsevier; 2007:521–527. 83. Tutuncu Z, Kavanaugh A. Rheumatic disease in the elderly: rheumatoid arthritis. Rheum Dis Clin North Am. 2007;33:57–70. 84. Majithia V, Peel C, Geraci SA. Rheumatoid arthritis in elderly patients. Geriatrics. 2009;64(9):22–28. 85. Wise CM. Crystal-induced arthritis in the elderly. Rheum Dis Clin North Am. 2007;33:33–55. 86. Kennedy S. Polymalgia rheumatica and giant cell arteritis: an in-depth look at diagnosis and treatment. J Am Acad Nurse Pract. 2012;24(6):277–285. 87. Kermani TA, Warrington KJ. Polymyalgia rheumatica. Lancet. 2013;383:63–72. 88. Van Hecke O. Polymyalgia rheumatica. Aust Fam Physician. 2011;40(5):303–306. 89. Falardeau J. Giant cell arteritis. Neurol Clin. 2010;28:581–591.

Porth Essentials Resources Explore these additional resources to enhance learning for this chapter: •  NCLEX-Style Questions and Other Resources

on

, http://thePoint.lww.com/PorthEssentials4e

• Study Guide for Essentials of Pathophysiology • Adaptive Learning | Powered by PrepU, http://thepoint.lww.com/ prepu